FierceBiotech 20. Feb. 2026 Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch
FierceBiotech 19. Feb. 2026 Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study
FierceBiotech 19. Feb. 2026 J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy
FierceBiotech 19. Feb. 2026 GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
FierceBiotech 19. Feb. 2026 NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports
FierceBiotech 18. Feb. 2026 Blood from pediatricians yields potential new medicines for respiratory viruses
FierceBiotech 18. Feb. 2026 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
FierceBiotech 18. Feb. 2026 Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug
FierceBiotech 18. Feb. 2026 Gut-focused Rasayana ingests gastrointestinal candidate in $36M licensing deal
FierceBiotech 18. Feb. 2026 Lilly pays CSL $100M upfront for IL-6 antibody that flunked a phase 3 organ transplant study
FierceBiotech 18. Feb. 2026 Korsana crosses into crowded Alzheimer's field with $175M and anti-amyloid antibody